SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

MITUMITU

info@mitu.or.tz | +255 28 2500019 | Staff Mail
  • LOGIN
  • WHO WE ARE
    • History & Background
    • Mission & Values
    • Strategic Plan
    • Organization Structure
    • Our Team
  • WHERE WE ARE
    • Mwanza Medical Research Centre
    • Mwanza City
  • WHAT WE DO
    • Research Programme
    • Capacity Building
    • Research Facilities
  • PUBLICATIONS
  • NEWS & EVENTS
    • News & Events
    • Career
  • CONTACT US
Thursday, 02 June 2022 / Published in 2022, Publication

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls – the DoRIS Randomised Trial.

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls – the DoRIS Randomised Trial.
Jones, D. W., Changalucha, J., Whitworth, H., Pinto, L. A., Mutani, P., Indangasi, J., Kemp, T. J., Hashim, R., Kamala, B., Wiggins, R., Songoro, T., Connor, N., Mbwanji, G., Pavon, M., Lowe, B., Mmbando, D., Kapiga, S., Mayaud, P., Dillner, J., … Baisley, K.
SSRN Electronic Journal.
DOI: https://doi.org/10.2139/ssrn.4055429.

What you can read next

Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study.
HIV prevention research: taking stock and the way forward.
Peer Counsellor Intervention for Reducing Mortality and/or Hospitalization in Adults with Hypertensive Urgency in Tanzania: A pilot study.

Filter by Year

  • All Publications
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

Recent Posts

  • Vacancy Announcement: Finance Officer

  • Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.

  • Hospitalization outcomes in people living with HIV on Dolutegravir-based regimen in Mwanza, Tanzania: a comparative cohort.

  • Vacancy Announcement: Laboratory Sample Archivist

  • HIV and CKD in the Tenofovir Era: A Prospective Parallel-Group Cohort Study From Tanzania.

Receive our latest news straight to your inbox

CONTACT US

Contact us through the address below
Mwanza Intervention Trials Unit.

MITU, Isamilo Street,
P.O. Box11936,
Mwanza, Tanzania.

info@mitu.or.tz

+255 28 2500019

WHO WE ARE

  • History & Background
  • Mission & Values
  • Strategic Plan
  • Organization Structure
  • Our Team

WHAT WE DO

  • Research Programme
  • Capacity Building
  • Research Facilities

OUR SOCIAL

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

OUR PARTNERS

Tweets by mituorg
© 2021 MITU | All rights reserved.
TOP